317 related articles for article (PubMed ID: 28467330)
21. Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?
Tocia C; Dumitru IM; Alexandrescu L; Petcu LC; Dumitru E
Medicine (Baltimore); 2021 Jan; 100(1):e24059. PubMed ID: 33429768
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study.
D'Amico F; Fiorini G; Tursi A; Saracino IM; Pavoni M; Danese S; Vaira D
J Gastrointestin Liver Dis; 2019 Dec; 28(suppl. 4):49-52. PubMed ID: 31930222
[TBL] [Abstract][Full Text] [Related]
23. Ultrasonographic and Functional Features of Symptomatic Uncomplicated Diverticular Disease.
Maconi G; Dell'Era A; Flor N; De Silvestri A; Lavazza A; Ardizzone S; Bassotti G
Clin Transl Gastroenterol; 2023 Jun; 14(6):e00580. PubMed ID: 36892507
[TBL] [Abstract][Full Text] [Related]
24. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
Rivkin A; Rybalov S
Pharmacotherapy; 2016 Mar; 36(3):300-16. PubMed ID: 26971716
[TBL] [Abstract][Full Text] [Related]
25. The Prevalence and Characteristics of Symptomatic Uncomplicated Diverticular Disease Among Asian Patients With Unexplained Abdominal Symptoms.
Jono T; Kasai Y; Kessoku T; Ogata T; Tanaka K; Yoshihara T; Misawa N; Kato S; Higurashi T; Hosono K; Yoneda M; Seita K; Kato T; Sakai E; Kurihashi T; Nakatogawa M; Oyamada S; Futagami S; Gwee KA; Nakajima A
J Neurogastroenterol Motil; 2024 Jan; 30(1):87-96. PubMed ID: 38012092
[TBL] [Abstract][Full Text] [Related]
26. Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
Cash BD; Lacy BE; Rao T; Earnest DL
Expert Opin Pharmacother; 2016; 17(3):311-22. PubMed ID: 26559529
[TBL] [Abstract][Full Text] [Related]
27. Performance of a multicompounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease.
Brandimarte G; Frajese GV; Bargiggia S; Castellani D; Cocco A; Colucci R; Evangelista E; Gravina AG; Napoletano D; Nardi E; Maisto T; Morabito A; Pianese G; Romano A; Sacco R; Sediari L; Sinnona N; Tifi L; D'Avino A; Elisei W; Tursi A
Minerva Gastroenterol (Torino); 2022 Jun; 68(2):216-222. PubMed ID: 35262307
[TBL] [Abstract][Full Text] [Related]
28. Role of dietary fibre in older adults with asymptomatic (AS) or symptomatic uncomplicated diverticular disease (SUDD): Systematic review and meta-analysis.
Eberhardt F; Crichton M; Dahl C; Nucera R; Jenkins J; Marx W; Marshall S
Maturitas; 2019 Dec; 130():57-67. PubMed ID: 31706437
[TBL] [Abstract][Full Text] [Related]
29. Colonic diverticular disease.
Tursi A; Scarpignato C; Strate LL; Lanas A; Kruis W; Lahat A; Danese S
Nat Rev Dis Primers; 2020 Mar; 6(1):20. PubMed ID: 32218442
[TBL] [Abstract][Full Text] [Related]
30. Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners.
Gatta L; Bellini M; Scarpignato C; Marrocco W; Chiriatti A; Grosso A; Lambiase C; Usai-Satta P; Vassallo R; Bartoletti P; Monica F; Manta R; Scotti S; Soncini M;
Intern Emerg Med; 2024 Jun; ():. PubMed ID: 38850356
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic delay in symptomatic uncomplicated diverticular disease: an Italian tertiary referral centre study.
Santacroce G; Lenti MV; Abruzzese GM; Alunno G; Di Terlizzi F; Frenna C; Gentile A; Latorre MA; Petrucci C; Ruggeri D; Soriano S; Aronico N; Rossi CM; De Silvestri A; Corazza GR; Di Sabatino A
Intern Emerg Med; 2024 Jan; 19(1):99-106. PubMed ID: 37891452
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group.
Papi C; Ciaco A; Koch M; Capurso L
Ital J Gastroenterol; 1992 Oct; 24(8):452-6. PubMed ID: 1330083
[TBL] [Abstract][Full Text] [Related]
33. Nerve fiber overgrowth in patients with symptomatic diverticular disease.
Barbaro MR; Cremon C; Fuschi D; Scaioli E; Veneziano A; Marasco G; Festi D; Stanghellini V; Barbara G
Neurogastroenterol Motil; 2019 Sep; 31(9):e13575. PubMed ID: 30838745
[TBL] [Abstract][Full Text] [Related]
34. Demographic and clinical features distinguish subgroups of diverticular disease patients: Results from an Italian nationwide registry.
Carabotti M; Cuomo R; Barbara G; Pace F; Andreozzi P; Cremon C; Annibale B
United European Gastroenterol J; 2018 Jul; 6(6):926-934. PubMed ID: 30023071
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease.
Bianchi M; Festa V; Moretti A; Ciaco A; Mangone M; Tornatore V; Dezi A; Luchetti R; De Pascalis B; Papi C; Koch M
Aliment Pharmacol Ther; 2011 Apr; 33(8):902-10. PubMed ID: 21366632
[TBL] [Abstract][Full Text] [Related]
36. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP;
N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.
Scaioli E; Colecchia A; Marasco G; Schiumerini R; Festi D
Dig Dis Sci; 2016 Mar; 61(3):673-83. PubMed ID: 26458921
[TBL] [Abstract][Full Text] [Related]
38. The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study.
Tursi A; Franceschi M; Elisei W; Picchio M; Mario FD; Brandimarte G
Ann Gastroenterol; 2021; 34(2):208-213. PubMed ID: 33654361
[TBL] [Abstract][Full Text] [Related]
39. [Non-distinctive abdominal pain: is it diverticular disease or not?].
Frieling T
Dtsch Med Wochenschr; 2024 Mar; 149(7):369-373. PubMed ID: 38479421
[TBL] [Abstract][Full Text] [Related]
40. Neurite outgrowth in symptomatic uncomplicated diverticular disease.
De Simone V; van Baarle L; Matteoli G
Neurogastroenterol Motil; 2019 Sep; 31(9):e13680. PubMed ID: 31411366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
